Syndax (SNDX) Up 15% in 6 Months — Analysts See $56 High
Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is a biotechnology company dedicated to developing innovative therapies that address some of the…
Trulieve Cannabis (TCNNF) Posts $302M Q2 Revenue but Still Reports $14M Net Loss
Trulieve Cannabis Corp. (OTC:TCNNF) is one of the largest and most established multi-state cannabis operators in the United…
BioCryst Pharmaceuticals (BCRX) Posted Q2 49.5% Revenue Surge
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is a biotechnology company dedicated to discovering and developing innovative oral therapies for rare…
Novo Nordisk (NVO) Crashes 21.83% in One Day
Novo Nordisk A/S (NYSE:NVO) is a global healthcare company with a history that spans more than a century,…
Connect Biopharma (CNTB) Trades at $1.63 With $7.00 Analyst Target
Connect Biopharma Holdings Limited (NASDAQ:CNTB) is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative therapies for…
Ocean Biomedical (OCEA) Warned Over Missed $612,581 Milestone
Ocean Biomedical, Inc. (NASDAQ:OCEA) is a clinical-stage biopharmaceutical company that was established with a mission to bridge the…
Greenwich LifeSciences (GLSI)’ GLSI-100 Cuts Breast Cancer Recurrence by 80% in Trials
Greenwich LifeSciences Inc. (NASDAQ:GLSI) is a clinical-stage biopharmaceutical company dedicated to developing novel immunotherapies designed to prevent breast…
SELLAS Life (SLS) Secures $23.6M to Fuel Late-Stage Cancer Trials
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is a late-stage clinical biopharmaceutical company dedicated to developing innovative therapies for…
Adicet (ACET) Falls Despite $150.4M Cash Runway Into 2026
Adicet Bio, Inc. (NASDAQ:ACET) is a clinical-stage biotechnology company focused on discovering and developing innovative allogeneic gamma delta…
Enlivex (ENLV) Reports $1.87M Q2 Loss, Cuts Cash Burn Nearly 40%
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) is a clinical-stage biopharmaceutical company based in Israel that is pioneering a novel approach…
BiomX (PHGE) Surges as BX211 Cuts Diabetic Wounds by 40%
BiomX Inc. (NASDAQ:PHGE) is a clinical-stage biotechnology company pioneering the development of bacteriophage-based therapies designed to target harmful…
MeiraGTx (MGTX) Reports $3.69M Revenue
MeiraGTx Holdings plc (NASDAQ:MGTX) is a clinical-stage gene therapy company dedicated to developing transformative treatments for patients with…
CytomX (CTMX) Boosts Cash to $158.1M After $100M Raise
CytomX Therapeutics Inc. (NASDAQ:CTMX) is a clinical-stage biotechnology company dedicated to transforming the treatment of cancer through its…
ABVC BioPharma (ABVC) Doubles Assets to $16.2M in Q2 2025
ABVC BioPharma Inc. (NASDAQ:ABVC) is a clinical-stage biopharmaceutical company that operates at the intersection of pharmaceutical innovation and…
Gossamer Bio (GOSS) Wins $10 Price Target
Gossamer Bio Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company founded with a mission to develop transformative therapies for…
IO Biotech (IOBT)’s Cancer Vaccine Shows 76% PFS Gain
IO Biotech Inc. (NASDAQ:IOBT) is a clinical-stage biopharmaceutical company pioneering the development of innovative cancer immunotherapies designed to…
Niagen Bioscience (NAGE) Up 503% in 3 Years
Niagen Bioscience, Inc. (NASDAQ:NAGE), formerly known as ChromaDex, is a science-driven company at the forefront of the healthy…
Corvus Pharmaceuticals (CRVS) Net Loss Doubles to $8M in Q2 2025
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to pioneering…